SIA A2Z Pharma · PEHero

◆PEHeroBetav0.8.0

Sessions

No sessions yet — send a message to start.

Agents

◉Deal Sourcing & Screening7▸

⚯Market Scannerscan:✓Deal Triage Agenttriage:≡Transaction Comps Findercomps:∿Owner Intent Signalintent:✉Outreach Email Drafteroutreach:📨Outreach Sequencersequence:✍LOI Writerloi:

◈LBO Underwriting Engine5▸

☰Cap Table Parsercap:∑LTM Financials Normalizerltm:▤LBO Model Builderlbo:▥Debt Stack Modelerdebt:◈Return Metricsret:

◆Due Diligence Stack5▸

☷VDR Auditorvdr:▢Contract Abstractorabstract:◰Legal & Regulatory Checkerlegal:⌂Operational Diligence Reviewerops:⚠ESG & Compliance Risk Flaggeresg:

◐Capital & LP Relations4▸

✎IC Memo Writermemo:✦Teaser Designerteaser:⇄LP Update Generatorlpupd:◎Fundraising CRM Copilotcrm:

◼Portfolio Operations4▸

↗Pricing Optimization Agentprice:ΔEBITDA Variance Watcherebitda:⚒Value Creation Prioritizervc:∠Customer Churn Predictorchurn:

Workspace

◆Pipeline ⊞Companies 📁Data Room ✎Instructions ∑Analytics ◎PE Valuation Simulator

⇄Integrations

⇄Pipedrive 🇪🇪Teatmik (EE)🇱🇹Rekvizitai (LT)🇱🇻data.gov.lv (LV)🇷🇴ONRC + ANAF (RO)🇵🇱KRS (PL)

🎓Training

📖User Guide 🏈PE Hero Game

Configuration

Currencyaffects agents + displays

▸Integrations3/9

Pipedrivepredictivelabsltdconnected

EE Äriregisterpublic endpointoff

EE EMTA (tax)off

LT Registrų centraspublic atviri duomenysoff

LT VMI (tax)off

LV URoff

LV VID (tax)off

Tavilydefaultconnected

EXAfallbackconnected

← Pipeline·SIA A2Z Pharma·SOURCED

Ask about SIA A2Z Pharma — the deal brief is on the right. Try 'triage this deal', 'draft IC memo', or 'summarize DD findings'.

Try a prompt

Deal brief

SIA A2Z Pharma

Business Services General SOURCED

HQ Rīga, LV

Employees 4

Founded 2018

Ownership founder

LTM financials

Revenue €12.3M

Adj. EBITDA €1.9M

Margin 15.6%

Ask EV €22M (11.5x)

Top customers

No contracts loaded.

DD findings

No findings yet. Try running VDR Auditor.

SIA A2Z Pharma is a Latvian company based in Rīga, operating in the General sector. The company employs 4 people. Annual revenue: €12,254,836.